Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

100

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

The network architecture of general intelligence in the human connectome

The network architecture of general intelligence in the...

44

MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesis

MCL1 modulates mTORC1 signaling to promote bioenergetic...

43

Deciphering the physiopathology of neurodevelopmental disorders using brain organoids

Deciphering the physiopathology of neurodevelopmental d...

111